Back to News
Welcome New Member: Swixx BioPharma d.o.o.
August 17, 2022

Welcome New Member: Swixx BioPharma d.o.o.

Swixx BioPharma is designed to fully replace biopharma, OTC and medical device multinationals across the counties of CEE and beyond, that the multinational chooses not to enter, or to exit.

With the sales likely to exceed 600M € in 2022, Swixx BioPharma is already the largest agent for ethical pharmaceuticals serving research-based biopharma in CEE. Swixx BioPharma began operations in December 2014. Today, Swixx’ real differentiator is our 1,000+ employees, dedicating every day to provide modern medicines to patients in need, with an innovative mindset and dynamic company culture. The company has gathered under one roof a unique group of experienced managers and medical professionals with expertise in rare disease, oncology-haematology, specialty, and self-medication. We are a service-oriented, high quality and ethically driven company. Swixx BioPharma d.o.o. employs 60 highly educated professionals in Croatia. For more information about Swixx, please visit:

Join AmCham

Join the leading international business community in Croatia.

Since 1998, AmCham Croatia represents business interests of American, international as well as Croatian companies. With more than 300 members, employing over 91.000 people, we are the voice of international business in Croatia. We are the first choice of international companies for policy advocacy in Croatia.

Join us now